This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Surgery  • Surgical Interventions  • Surgical Interventions, Other  • Surgery, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Susan Galandiuk, MD; Dora Allen, CPC

Arch Surg. 2009;144(6):496-497.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The subtle and not-so-subtle influence of industry on physicians has lately become a front-burner issue. Device makers and surgeons are coming under ever greater scrutiny. Although ventral, incisional, or inguinal hernia repair, with or without prosthetic material, is a fairly routine procedure, it is in fact one of the areas in need of greatest reassessment, in substantial part because of the massive associated hospital cost. For example, a 16 x 20–cm biologic product can cost up to $10 099! The cost of such a product alone, in this instance, is more than 5 times what the most highly reimbursed surgeon receives for all of his or her care including preoperative assessment, surgery, postoperative care, and office follow-up; further, it is 10 times what America's average surgeon receives for the same effort!

Think further. The durability of such nonpermanent material is highly questionable, and the likelihood . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Medication Costs Matter
Morse
Arch Ophthalmol 2009;127:929-931.
FULL TEXT